Burt Richards

Burt Richards

Auto-generated profile, based on publicly available information

Burt Richards

Sharon Eccles Steele Center for Translational Medicine, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Dr, Salt Lake City, UT 84132, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2008 in Journal of Natural Products
Verified
Journal Article
Open access
TBTim S. Bugni
Tim S. Bugni
BRBurt Richards
Burt Richards
LBLeen Bhoite
Leen Bhoite
DCDaniel Cimbora
Daniel Cimbora
MHMary Kay Harper
Mary Kay Harper
Chris IrelandChris Ireland
Chris Ireland
There is a need for diverse molecular libraries for phenotype-selective and high-throughput screening. To make marine natural products (MNPs) more amenable to newer screening paradigms and shorten discovery time lines, we have created an MNP library characterized online using MS. To test the potential of the library, we screened a subset of the library in a phenotype-selective screen to identify compounds that inhibited the growth of BRCA2-deficient cells.

5 September 1997 in Science
Verified
Journal Article
Closed access
PDF file
BRBurt Richards
Burt Richards
HZHong Zhang
Hong Zhang
GPGeraldine Phear
Geraldine Phear
MMMark Meuth
Mark Meuth
Two human tumor cell lines that are deficient in the mismatch repair protein hMSH2 show little or no increase in mutation rate relative to that of a mismatch repair–proficient cell line when the cells are maintained in culture conditions allowing rapid growth. However, mutations accumulate at a high rate in these cells when they are maintained at high density. Thus the mutator phenotype of some mismatch repair–deficient cell lines is conditional and strongly depends on growth conditions. These observations have implications for tumor development because they suggest that mutations may accumulate in tumor cells when growth is limited.

1 July 1999
Verified
Journal Article
Closed access
HZHong Zhang
Hong Zhang
BRB Richards
B Richards
TWT Wilson
T Wilson
MLM Lloyd
M Lloyd
ACA Cranston
A Cranston
MMM Meuth
M Meuth

22 July 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
BWBrandi L Williams
Brandi L Williams
NSNathan A Seager
Nathan A Seager
JGJamie D Gardiner
Jamie D Gardiner
CPChris M Pappas
Chris M Pappas
MCMonica C Cronin
Monica C Cronin
GHGregory S Hageman
Gregory S Hageman
Significance: The chromosome 10q26 locus is the genetic region most strongly associated with elevated risk of age-related macular degeneration (AMD), but the underlying genetic defects initiating disease are unresolved. Using human-derived eye tissues, we demonstrate that mRNA encoding the serine protease, HTRA1, is reduced in the retinal pigment epithelium (RPE) of donors with risk-associated variants that disrupt a cis-regulatory element within the 10q26 locus. Consequentially, there is diminished HtrA1 protein within the RPE–Bruch’s membrane interface, the primary site of AMD initiation, with age. This indicates that HtrA1 functions to maintain the integrity of this interface during the aging process and that HtrA1 levels are impaired by chromosome 10q26 risk-associated variants. HtrA1 augmentation may be a viable therapeutic option for AMD.

1 March 2010 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MBMatthew G. Bursavich
Matthew G. Bursavich
DPDaniel P. Parker
Daniel P. Parker
JWJ. Adam Willardsen
J. Adam Willardsen
ZGZhong-Hua Gao
Zhong-Hua Gao
TDThaylon Davis
Thaylon Davis
BRBurt Richards
Burt Richards

10 June 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WJWeston R. Judd
Weston R. Judd
PSPaul M. Slattum
Paul M. Slattum
KHKhanh C. Hoang
Khanh C. Hoang
LBLeena Bhoite
Leena Bhoite
LVLiisa Valppu
Liisa Valppu
JWJ. Adam Willardsen
J. Adam Willardsen